Editor's note: On the 20th anniversary of the Dietary Supplements Health and Education Act, New Hope Natural Media asked several experts to weigh in on the current regulatory atmosphere in the supplements space. Here, Alkemist Labs' Elan Sudberg shares his prediction for the future of the category.

Elan Sudberg, CEO

August 27, 2014

1 Min Read
The next big player in supplements

I’m confident genetic-based personalized medicine will be a massive part of the industry over the next 20 years. Quality will still be a critical success factor, hopefully made simpler and less expensive by new technologies. I don’t know what to expect from the regulatory side. Since FDA seems to respond to hysteria so quickly, it’s hard to tell what a handful of future, serious adverse events or recalls might produce. Maybe clinical studies will decrease in cost and allow our industry to make new claims. I hope there are some new botanicals discovered, and their properties put to use.

Will botanicals make a difference?
Will clinical studies change industry clout?

About the Author(s)

Elan Sudberg

CEO, Alkemist Labs

Élan M. Sudberg is CEO of Alkemist Labs, a passionately committed contract testing laboratory specializing in plant and fungal identity, potency and purity testing for the food, beverage, nutraceutical and psychedelic industries. His favorite part of his job is catching cheaters, and he is known for pushing the industry to continually raise the bar on quality and transparency. Élan holds a degree in chemistry from California State University Long Beach, and he is on the American Herbal Products Association (AHPA) board of trustees.

Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.

You May Also Like